Avecho Biotechnology

(ASX) AVE

Current Price$0.01

Market Cap$44.08M

Since IPO (1993)-96%

5 Year-43%

1 Year+200%

1 Month+50%

Avecho Biotechnology Financials at a Glance

Market Cap

$44.08M

Revenue (TTM)

$2.37M

Net Income (TTM)

$7.54M

EPS (TTM)

$-0.00

P/E Ratio

-8.57

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$0.01

Volume

11,330,444

Open

$0.01

Price

$0.01

Volume

11,330,444

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$0.01

Volume

11,330,444

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

AVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avecho Biotechnology

Industry

Pharmaceuticals

Sector

Health Care

CEO

Paul David Gavin, PhD

Website

www.avecho.com.au

Headquarters

Clayton, VIC 3168, AU

AVE Financials

Key Financial Metrics (TTM)

Gross Margin

61%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-183%

Return on Capital

-94%

Return on Assets

-62%

Earnings Yield

-11.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.08M

Shares Outstanding

3.67B

Volume

11.33M

Avg. Volume

6.22M

Financials (TTM)

Gross Profit

$751.29K

Operating Income

$6.00M

EBITDA

$5.87M

Operating Cash Flow

$1.10M

Capital Expenditure

$0.00

Free Cash Flow

$1.10M

Cash & ST Invst.

$4.66M

Total Debt

$14.47K

Avecho Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$957.73K

+3432.5%

Gross Profit

$553.84K

+315.0%

Gross Margin

57.83%

N/A

Market Cap

$44.08M

N/A

Market Cap/Employee

$1.52M

N/A

Employees

N/A

Net Income

$3.08M

-135.2%

EBITDA

$4.60M

-139.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.65M

-12.8%

Accounts Receivable

$2.20M

+100.5%

Inventory

$8.07K

-91.7%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$14.47K

-90.6%

Return on Assets

-62.15%

N/A

Return on Invested Capital

-93.86%

N/A

Free Cash Flow

$3.43M

-23.4%

Operating Cash Flow

$3.43M

-23.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NC6.AXNanollose Limited

NC6.AXNanollose Limited$0.08-3.70%

AGH.AXAlthea Group Holdings Limited

AGH.AXAlthea Group Holdings Limited$0.02-4.76%

BTC.AXBTC Health Limited

BTC.AXBTC Health Limited$0.05+0.00%

MDR.AXMedAdvisor Limited

MDR.AXMedAdvisor Limited$0.02+0.00%

FRE.AXFirebrick Pharma Limited

FRE.AXFirebrick Pharma Limited$0.05-3.64%

NTI.AXNeurotech International Limited

NTI.AXNeurotech International Limited$0.01+0.00%

PAB.AXPatrys Limited

PAB.AXPatrys Limited$0.03+1.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.37+0.07%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.01%

NIONio

NIONio$5.87-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.15-0.03%

OWLBlue Owl Capital

OWLBlue Owl Capital$10.04+0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.30-0.07%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$674.22+0.01%

Questions About AVE

What is the current price of Avecho Biotechnology?

Avecho Biotechnology is trading at A$0.01 per share.

What is the 52-week range for Avecho Biotechnology?

Over the past 52 weeks, Avecho Biotechnology has traded between A$0.00 and A$0.01.

How much debt does Avecho Biotechnology have?

As of the most recent reporting period, Avecho Biotechnology reported total debt of $14,473.

How much cash does Avecho Biotechnology have on hand?

Avecho Biotechnology reported $4.66M in cash and cash equivalents in its most recent financial results.

What is Avecho Biotechnology’s dividend yield?

Avecho Biotechnology does not currently have a dividend yield.

Avecho Biotechnology

Avecho Biotechnology Financials at a Glance

AVE News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Avecho Biotechnology

AVE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Avecho Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AVE

What is the current price of Avecho Biotechnology?

What is the 52-week range for Avecho Biotechnology?

How much debt does Avecho Biotechnology have?

How much cash does Avecho Biotechnology have on hand?

What is Avecho Biotechnology’s dividend yield?

Premium Investing Services